AVD SEC Filings - American Vanguard Corp 10-K, 10-Q, 8-K Forms
This page on StockTitan provides access to American Vanguard Corporation's (AVD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It details the types of information found in these filings, such as operating results, capital structure, governance actions, and identifies the most recent filing as July 29, 2025. StockTitan offers AI-generated summaries, impact scoring, and sentiment analysis for these documents.
American Vanguard director Patrick Gottschalk buys $67,500 in stock
American Vanguard director Patrick Gottschalk recently purchased 25,000 shares of the company's common stock for $67,500, increasing his direct holdings to 191,705 shares. This insider purchase comes as the stock trades near $2.67, significantly below its InvestingPro Fair Value of $4.12, suggesting potential undervaluation. Additionally, American Vanguard reported strong first-quarter 2026 financial results, exceeding revenue expectations with $124 million in net sales, attributed to robust domestic performance despite international headwinds.
American Vanguard (AVD) director adds 25,000 shares at $2.70
American Vanguard Corp (AVD) director Patrick E. Gottschalk reported an open-market purchase of 25,000 shares of Common Stock at $2.70 per share, increasing his direct holdings to 191,705 shares. This transaction, made on May 19, 2026, signals increased confidence and a larger personal stake in the company. The Form 4 filing details the acquisition and confirms it was a positive net-buy transaction with no derivative securities involved.
American Vanguard: director Patrick Gottschalk buys $117,400 in stock
American Vanguard director Patrick Gottschalk recently purchased $117,400 worth of company stock through open market transactions, buying 40,000 shares at prices ranging from $2.92 to $2.95. This comes as the stock (NYSE: AVD) has fallen 39% in the past six months to trade at $2.67. The company also announced strong Q1 2026 results, exceeding revenue expectations with $124 million in net sales.
Director adds 40,000 American Vanguard (AVD) shares in open-market buys
American Vanguard Corp (AVD) director Patrick E. Gottschalk purchased 40,000 shares of common stock in open-market transactions on May 12 and May 13, 2026. He bought 20,000 shares at $2.92 and another 20,000 shares at $2.95, increasing his direct holdings to 166,705 shares. This insider buying signals positive sentiment towards the company.
Top American Vanguard (AVD) Competitors 2026
This article provides a detailed comparison of American Vanguard (AVD) with its key competitors: CF Industries (CF), Mosaic (MOS), Scotts Miracle-Gro (SMG), Intrepid Potash (IPI), and NL Industries (NL). It analyzes each pair based on various financial metrics like earnings, valuation, profitability, institutional ownership, media sentiment, risk, and analyst recommendations. The comparisons offer insights for investors to determine which basic materials company might be a better investment.
AVD Price Today: American Vanguard Corporation Stock Price, Quote & Chart | MEXC
American Vanguard Corporation (AVD) is currently trading at $2.94, down 3.73% from its previous close. The company operates in the agricultural chemicals sector, manufacturing specialty solutions and products. AVD has shown a +17.13% return over the past month but a -29.67% change over the last 12 months, indicating weak performance relative to the broader market.
American Vanguard Corporation Q1 10-Q Filing: Financial Statements, Risks, and Legal Proceedings Overview
American Vanguard Corporation (NYSE: AVD) reported a significant improvement in its financial performance for Q1 2026, narrowing its net loss to $4.1 million and returning to positive operating income of $1.9 million. The company's total assets increased to $665.2 million, and it maintains compliance with NYSE listing requirements. Despite these improvements, the company still faces challenges including an asset impairment charge and substantial interest expenses.
Earnings call transcript: American Vanguard Q1 2026 beats revenue expectations
American Vanguard Corporation (AVD) reported Q1 2026 net sales of $124 million, surpassing expectations by $4 million, driven by strong U.S. domestic sales. The company achieved a 7% year-over-year increase in sales and a 245% surge in Adjusted EBITDA, leading to a 1.36% stock price rise in aftermarket trading. Despite international headwinds and increased debt, American Vanguard plans to launch 50 new products over the next five years, aiming for $100 million in annualized revenue by 2030, and projects Adjusted EBITDA of $44 million-$48 million for 2026.
American Vanguard: Q1 Earnings Snapshot
American Vanguard Corp. (AVD) reported a first-quarter loss of $4.1 million, translating to a loss of 14 cents per share. The agricultural products company generated $123.6 million in revenue during the period. The company's shares were trading at $2.90 at the close of Wednesday, down from $4.25 a year ago.
American Vanguard: Q1 Earnings Snapshot
American Vanguard Corp. (AVD) reported a first-quarter loss of $4.1 million, or 14 cents per share. The agricultural products company posted revenue of $123.6 million for the period. Shares of American Vanguard were trading at $2.90, down from $4.25 a year ago.
American Vanguard: Q1 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q1 loss of $4.1 million, or 14 cents per share. The agricultural products company posted revenue of $123.6 million for the period. Shares closed at $2.90 on Wednesday, down from $4.25 a year ago.
American Vanguard (AVD.US) will release its earnings report after the market closes on May 6.
American Vanguard (AVD.US) is scheduled to release its earnings report after the market closes on May 6. Investors will be keenly watching the report for insights into the company's financial performance.
American Vanguard launches iNvigorate to enhance nutrient uptake and soil optimization
American Vanguard has introduced iNvigorate, a new microbial network product designed to boost crop growth and yield potential. This product works by using microbial activity to improve nutrient availability and uptake, thereby optimizing soil conditions for healthier crops. This launch follows the earlier introduction of B Sure liquid biostimulant, marking American Vanguard's ongoing efforts to offer solutions that enhance agricultural productivity and address farming challenges.
American Vanguard (AVD) Expected to Announce Quarterly Earnings on Monday
American Vanguard (AVD) is scheduled to announce its Q1 2026 earnings before market open on Monday, May 11th. Analysts anticipate an EPS of ($0.06) and revenue of $120.00 million. The company's prior quarter results missed estimates, and its stock traded down by 6.2% following that report.
American Vanguard to post Q1 results after close, webcast at 4:30 ET
American Vanguard (NASDAQ: AVD) announced it will report its first-quarter 2026 financial results after market close on Wednesday, May 6, 2026. The company will also host a live earnings conference call and webcast on the same day at 4:30 pm ET, led by CEO Dak Kaye and CFO David Johnson. The webcast will be accessible on the company's investor website and archived for one year.
American Vanguard Corporation (NYSE:AVD) Short Interest Up 35.3% in March
American Vanguard Corporation (NYSE:AVD) experienced a significant 35.3% increase in short interest during March, reaching 949,010 shares as of March 31st. The company reported disappointing quarterly earnings, missing analyst expectations with $0.06 EPS against $0.28 expected, and revenue of $150.69M versus $163M. Despite these financial setbacks, American Vanguard's stock traded up 5.2% intraday to $2.75, though analysts currently rate the stock as a "Hold" with an average target price of $12.00.
Three American Vanguard (NYSE: AVD) directors to leave board in 2026
American Vanguard Corporation announced that three current directors, Scott Baskin, Emer Gunter, and Carmen Tiu de Mino, will not seek re-election at the 2026 annual meeting. This decision is linked to a prior agreement under a First Lien Term Loan, which mandates reducing the Board from nine to seven members and adding an independent director. The company clarified that the directors' departures are not due to any disputes regarding operations or policies.
American Vanguard (NYSE:AVD) - Stock Analysis
This report provides a comprehensive stock analysis of American Vanguard (NYSE: AVD), detailing its market performance, financial health, risk factors, and future growth prospects. Despite being 78.3% undervalued according to analyst consensus and having strong potential in green solutions, the company faces significant risks including declining earnings, volatile share price, and a relatively small market capitalization. The analysis highlights key financial metrics, recent news, and compares AVD's performance against industry and market benchmarks.
American Vanguard launches B Sure liquid biostimulant to boost crop productivity and resilience
American Vanguard has introduced B Sure, a new liquid biostimulant aimed at enhancing plant development and improving crop resilience to stress. This product is compatible with a variety of crops and is designed to increase overall productivity, meeting the growing demand for sustainable agricultural solutions. The company expects B Sure to help farmers achieve stronger and more robust plant growth.
AVD Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial analysis of American Vanguard Corp (AVD), detailing its revenue breakdown, profitability margins, and a comparison with competitors. AVD generates most of its revenue from herbicides/soil fumigants/fungicides, accounting for 50.7% of total sales. The company's financial health is examined through its gross margin (26.32%), operating margin (5.28%), net margin (-18.72%), and Return on Equity (-23.45%), with a competitive benchmark against FNUC and BIOX.
Vanguard disaggregates holdings; reports 0 shares of American Vanguard Corp (AVD)
The Vanguard Group has amended its Schedule 13G filing for American Vanguard Corp (AVD), reporting 0 shares beneficially owned as a result of an internal realignment on January 12, 2026. This change disaggregates holdings, with subsidiaries now reporting separately. The filing indicates this is an administrative change, not a sale of shares, and cash-flow treatment or holdings by other Vanguard entities are not detailed.
American Vanguard Corp stock faces regulatory headwinds amid chemical sector volatility and environm
American Vanguard Corp (ISIN: US03027X1000) is navigating significant challenges in the agricultural chemical sector due to tightening environmental regulations and fluctuating market dynamics. As a specialty chemical company, it focuses on crop protection and pest control products, balancing innovation with sustainability demands. The stock's performance is influenced by broader industry pressures, feedstock volatility, and the need to adapt to integrated pest management trends, with no major new catalysts reported recently.
American Vanguard Corporation share price
This article provides details on American Vanguard Corporation (AVD) stock, including its current price ($2.33 as of March 24, 2026), 52-week high and low, key financial metrics like market cap and revenue, and historical returns. It also offers brief information on how to invest in US stocks and answers frequently asked questions about the company.
American Vanguard Raises $285 Million in New First- and Second-Lien Term Loans, Retires Prior Facility
American Vanguard, through its subsidiary AMVAC, successfully completed a $285 million refinancing on March 13, 2026. This involved securing new first-lien and second-lien term loans and retiring its previous 2021 credit agreement. The company expects this new financial structure to enhance liquidity and better align with its current operating needs.
American Vanguard (NYSE: AVD) adds $285M first- and second-lien debt
American Vanguard Corporation (NYSE: AVD), through its subsidiary AMVAC Chemical, has secured new first- and second-lien term loans totaling $285 million. These loans, consisting of a $225 million first-lien facility and a $60 million second-lien facility, will be used to refinance existing debt and provide approximately $68.5 million for general corporate and working capital purposes. The new financing comes with specific interest rates, maturity dates, and governance provisions, including board size reduction and independent director approval for certain actions.
American Vanguard Reports FY2025: $515.1M Sales, $39.2M Adjusted EBITDA, $49.9M Net Loss
American Vanguard (AVD) reported its full-year 2025 financial results, with net sales reaching $515.1 million and adjusted EBITDA at $39.2 million. The company's GAAP net loss significantly narrowed to $49.9 million from $126.3 million in 2024, attributed to improved gross margin and reduced operating costs. Key business highlights include securing $285 million in new term loans, rationalizing a manufacturing facility, and planning a corporate headquarters relocation for efficiency and savings.
American Vanguard (NYSE: AVD) trims 2025 loss, guides higher EBITDA on cost cuts
American Vanguard reported a narrower net loss in 2025 due to improved gross margins and cost controls, despite a 6% decline in net sales. The company provided optimistic guidance for 2026, projecting higher Adjusted EBITDA and sales, driven by facility rationalization, headquarters relocation, and new product launches aimed at generating significant future revenue. They also successfully remediated all material weaknesses identified in the 2024 audit and refinanced their credit facility.
American Vanguard Reports Full Year 2025 Results
American Vanguard Corporation announced its financial results for the full year 2025, reporting a decline in net sales but an increase in adjusted EBITDA. The company extended and expanded its credit capacity with two new term loan agreements totaling $285 million and plans to rationalize its Los Angeles manufacturing facility to improve efficiency. American Vanguard forecasts adjusted EBITDA of $44-$48 million in 2026, signaling efforts to strengthen its capital structure and improve operational efficiency amidst a recovering agricultural market.
Earnings call transcript: American Vanguard’s Q4 2025 revenue misses target
American Vanguard Corporation reported a 6% revenue decline in 2025, reaching $515 million, below its target. CEO Douglas Kaye highlighted initiatives like rationalizing manufacturing, new product development, and cost reduction to improve future profitability and reduce debt. The company projects adjusted EBITDA of $44 million-$48 million on sales of $530 million-$550 million for 2026, aiming for a long-term EBITDA margin of 15%.
American Vanguard: Fourth Quarter Earnings Overview
American Vanguard Corp. reported a net loss of $28.2 million, or 99 cents per share, for the fourth quarter, with adjusted earnings of 6 cents per share. The agricultural products firm generated $150.7 million in revenue during this period. For the full year, the company's net loss was $49.9 million, or $1.75 per share, on revenues of $515.1 million.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a significant net loss of $28.2 million, or 99 cents per share, in its fourth quarter, though adjusted earnings reached 6 cents per share. The agricultural products company posted revenue of $150.7 million for the quarter. For the full year, the company's loss narrowed to $49.9 million on revenue of $515.1 million.
American Vanguard (NYSE:AVD) Posts Quarterly Earnings Results, Misses Estimates By $0.22 EPS
American Vanguard (NYSE:AVD) reported quarterly earnings of $0.06 per share, significantly missing analysts' consensus estimate of $0.28 per share by $0.22. The basic materials company also reported revenue of $150.69 million, falling short of the estimated $163.00 million. Despite these misses, the company highlighted recent debt refinancing, operational rationalization expected to save millions annually, and a projected product-driven growth runway with ambitious revenue targets for 2030-31.
American Vanguard Q4 Loss: $28.2M, Revenue $150.7M | 2026 Report - News and Statistics
American Vanguard Corp. reported a net loss of $28.2 million, or 99 cents per share, for the final quarter of its fiscal year, with quarterly revenue reaching $150.7 million. Adjusted earnings were 6 cents per share. For the full year, the company's financial loss was $49.9 million, or $1.75 per share, on annual revenue of $515.1 million, and its share price closed at $4.07 on the day of the report, lower than the previous year.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q4 loss of $28.2 million, or 99 cents per share, with adjusted earnings of 6 cents per share. The company's revenue for the quarter was $150.7 million, while its full-year loss narrowed to $49.9 million on $515.1 million in revenue. Shares were trading at $4.07, down from $4.43 a year prior.
American Vanguard: Fourth Quarter Earnings Overview
American Vanguard Corp. reported a net loss of $28.2 million for the fourth quarter, or 99 cents per share, though adjusted earnings were 6 cents per share. The company generated $150.7 million in revenue for the quarter. For the full year, the net loss totaled $49.9 million with annual revenue reaching $515.1 million.
American Vanguard 2025 10-K: $515.1M Revenue, $(1.75) EPS
American Vanguard reported net sales of $515.1 million for 2025, a 6% decrease from 2024, resulting in a net loss of $49.9 million or $(1.75) per share. Despite the decline in revenue, the company improved its gross profit and narrowed its operating loss, highlighting recovery in margins due to eased cost pressures and operational restructuring.
Earnings call transcript: American Vanguard’s Q4 2025 revenue misses target
American Vanguard reported a 6% decline in revenue for 2025, reaching $515 million, which fell short of its target range. Despite missing revenue, the company improved its gross profit margin to 29% and is implementing cost-cutting measures, including closing its Los Angeles manufacturing facility and relocating its headquarters. For 2026, American Vanguard forecasts sales between $530 million and $550 million, with a focus on new product launches and operational efficiencies to drive future growth and profitability.
American Vanguard Corporation (AVD) Stock Falls on Q4 2025 Earnings
American Vanguard Corporation (AVD) reported fourth-quarter 2025 earnings showing a significant decline in revenue and net income, missing analyst estimates. Total revenues dropped 9.0% year-over-year to $150.7 million, with a net loss of -$28.2 million. The stock reacted negatively, falling 1.68% since market close.
American Vanguard: Q4 Earnings Snapshot
American Vanguard Corp. (AVD) reported a Q4 loss of $28.2 million, or 99 cents per share, with adjusted earnings of 6 cents per share. The company's revenue for the quarter was $150.7 million. For the full year, American Vanguard's loss narrowed to $49.9 million on revenues of $515.1 million.
American Vanguard (AVD) Quarterly Loss Deepens Margin Concerns And Challenges Profitability Narrative
American Vanguard (AVD) reported mixed Q3 FY 2025 results with deepened losses, impacting its profitability narrative. Despite some analyst optimism about margin expansion and growth, the company's trailing twelve-month figures show significant losses and poor debt coverage. The market reflects this concern with a low P/S ratio, highlighting a disconnect between growth projections and current financial performance.
American Vanguard Corporation (AVD) Stock Falls on Q4 2025 Earnings
American Vanguard Corporation (AVD) reported a significant decline in its Q4 2025 earnings, with revenues down 9.0% year-over-year to $150.7 million and a net loss of -$28.2 million. The diluted EPS also fell substantially to -$0.99. Both revenue and EPS missed analyst estimates, causing the stock to drop by 1.68% since market close.
American Vanguard Announces Date of Full Year 2025 Earnings Release and Webcast Conference Call
American Vanguard Corporation announced that it will release its full-year 2025 financial results on Monday, March 16, 2026, after the market closes. The company will also host an earnings conference call and webcast on the same day at 4:30 pm ET, led by CEO Dak Kaye and CFO David T. Johnson. The webcast will be available on the company's website and archived for one year.
AVD SEC Filings - American Vanguard Corp 10-K, 10-Q, 8-K Forms
This page provides access to American Vanguard Corp (AVD) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, and 8-K material event forms, with AI-powered summaries to help investors. It details the company's financial performance, operational developments, and governance disclosures. Recent Q2-25 filings show a narrowed loss despite tightened credit terms, highlighting the company's efforts to manage debt and operational costs.
American Vanguard (AVD) Expected to Announce Earnings on Wednesday
American Vanguard (AVD) is scheduled to release its Q4 2025 earnings before market open on Wednesday, March 11th. Analysts project earnings per share of $0.28 and revenue of $163.0 million. The basic materials company has seen high institutional ownership and a "Hold" consensus rating from Wall Street, with a target price of $12.00.
Short Interest in American Vanguard Corporation (NYSE:AVD) Declines By 28.2%
Short interest in American Vanguard Corporation (NYSE:AVD) decreased by 28.2% in February, falling to 662,079 shares, which represents about 2.5% of the stock. With an average daily trading volume, the days-to-cover ratio is 3.9 days. Analysts have mixed views, with a consensus "Hold" rating and a target price of $12.00, while institutional investors hold 79.00% of the company's stock.
American Vanguard (NYSE:AVD) Stock Crosses Above 200-Day Moving Average - Should You Sell?
American Vanguard (NYSE:AVD) briefly traded above its 200-day moving average of $4.87 on Thursday but closed down approximately 3.9% at $4.72. Analyst sentiment for AVD is mixed, with ratings ranging from "hold" to "sell" and an average price target of $12.00. The company is a small-cap entity specializing in specialty chemical products, with significant institutional ownership and a debt-to-equity ratio of 0.82.
American Vanguard (NYSE:AVD) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?
American Vanguard (NYSE:AVD) stock recently crossed above its 200-day moving average, trading as high as $5.35 before settling at $5.2440. Despite this, analyst sentiment remains mixed, with a consensus "Hold" rating and a target price of $12.00, alongside some "Sell" and "Hold" recommendations. The company has a market capitalization of $149.3 million, a negative P/E ratio, and significant institutional ownership.
American Vanguard to Relocate to Irvine Co.’s Discovery Park
American Vanguard Corp. is moving its corporate headquarters from Newport Beach to Irvine Company’s Discovery Park in Irvine, a strategic relocation aimed at reducing costs and improving efficiency. The pesticide and agricultural products manufacturer expects the move to be completed by the end of the second quarter of 2026. This decision follows recent leadership changes and is part of a broader initiative to streamline operations and optimize the company's real estate footprint.
Essex Investment Management Co. LLC Purchases Shares of 372,064 American Vanguard Corporation $AVD
Essex Investment Management Co. LLC has acquired a new stake of 372,064 shares in American Vanguard Corporation (NYSE:AVD) during the third quarter, valued at approximately $2.14 million. This purchase contributes to institutional and hedge funds collectively owning about 79% of the company. Despite these institutional investments, analyst sentiment for American Vanguard is mixed, with a consensus "Hold" rating and an average price target of $12.00, although the company is currently operating at a loss.
